References
- Global Initiative for Chronic Obstructive Lung Disease (GOLD)2011 Available from: http://www.goldcopd.org/Accessed January 25, 2016
- LangePMarottJLVestboJPrediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationAm J Respir Crit Care Med20121861097598122997207
- HaughneyJGruffydd-JonesKRobertsJLeeAJHardwellAMcGarveyLThe distribution of COPD in UK general practice using the new GOLD classificationEur Respir J2014434993100224176990
- JonesPMiravitllesMvan der MolenTKulichKBeyond FEV1 in COPD: a review of patient-reported outcomes and their measurementInt J Chron Obstruct Pulmon Dis2012769770923093901
- WestwoodMBourbeauJJonesPWCerulliACapkun-NiggliGWorthyGRelationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic reviewRespir Res2011124021477298
- TsiligianniIKocksJTzanakisNSiafakasNvan der MolenTFactors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlationsPrim Care Respir J201120325726821472192
- BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
- FletcherCMElmesPCFairbairnASWoodCHThe significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working populationBr Med J19592514725726613823475
- RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med200717653255517507545
- VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
- NadeauGAdamekLSmallMDistribution of COPD patients in the GOLD assessment framework by exacerbationsEur Respir J201240Suppl 56p980
- MapelDWDalalAAJohnsonPTBeckerLKHunterAGApplication of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severityInt J Chron Obstruct Pulmon Dis2015101477148626251587
- HogendoornMFeenstraTLHoogenveenRTAlMMölkenMRAssociation between lung function and exacerbation frequency in patients with COPDInt J Chron Obstruct Pulmon Dis2010543544421191438
- AgustiACalverleyPMACelliBCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
- Echave-SustaetaJMComeche CasanovaLCosioBGSoler-CataluñaJJGarcia-LujanRRiberaXComorbidity in chronic obstructive pulmonary disease. Related to disease severity?Int J Chron Obstruct Pulmon Dis201491307131425429213
- KimSOhJKimYIDifferences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analysesBMC Pulm Med2013133523731868
- MenezesAMBPerez-PadillaRJardimJRBChronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence studyLancet200536695001875188116310554